A 61‐year‐old man of European ancestry (Fitzpatrick skin type II) presented with five large fungating lesions (Box 1). These tumours had been progressively growing over a 12‐month period. The presentation of this patient was delayed as he had initially misattributed the lesions to ingrown hairs. He had no personal or family history of melanoma or non‐melanoma skin cancers. He had no personal medical history of autoimmune conditions, recurrent infections, or immunosuppression.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Good RA, Varco RL. A clinical and experimental study of agammaglobulinemia. J Lancet 1955; 75: 245‐271.
- 2. Kelesidis T, Yang O. Good's syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clin Immunol 2010; 135: 347‐363.
- 3. Zaman M, Huissoon A, Buckland M, et al. Clinical and laboratory features of seventy‐eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia). Clin Exp Immunol 2019; 195: 132‐138.
- 4. Griffiths CEM, Barfer J, Bleiker TA, et al; editors. Rook's textbook of dermatology, 4 volume set, 9th ed. Chichester (UK): Wiley Blackwell, 2016.
- 5. O'Reilly Zwald F, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 263‐279.
Patient consent: The patient gave written consent for publication.
No relevant disclosures.